Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial – - Data presented at AACR 2023 supports ...
Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...
TikTok parent company ByteDance unveils OmniHuman, an AI system that can generate realistic videos of people from just one ...
Ramona, a Durham provider of advanced imaging technology for life sciences, has launched a live-cell imaging system that ...
Hershey beat fourth-quarter profit and sales estimates as the chocolate maker's price hikes helped offset the higher cost of cocoa.
The ultra-thin lens offering from Viltrox will soon be available in what the brand calls a "new flavor" for X-mount users.